Schwazze FY22 Revenue Grows 47% To $159.4M, What About Adjusted EBITDA?

Medicine Man Technologies Inc. operating as Schwazze, SHWZ SHWZ, announced financial results for the Q4 2022 and for the year ended December 31, 2022, revealing revenue of $159.4 million, an increase of 47% compared to $108.4 million in 2021.

Q4 2022 Financial Highlights

  • Revenues of $40.1 million, an increase of 51% compared to $26.5 million in Q4 2021

  • Gross profit of $23.0 million, an increase of 89% compared to Q4 2021

  • Net loss of $27.3 million compared to net income of $12.8 million for Q4 2021

  • Adjusted EBITDA of $13.3 million was 33% of revenue, compared to $7.5 million and 28% of revenue for Q4 2021

Full Year 2022 Financial Highlights

  • Gross profit of $85.0 million, an increase of 72% compared to $49.4 million in 2021

  • Gross profit margin rose as a percentage of revenue from 46% to 53%.

  • Net loss of $18.5 million compared to net income of $14.5 million for 2021, driven by an impairment charge of $8.0 million, interest expense of $30.1 million, and loss on disposition of assets of $4.7 million

  • Adjusted EBITDA of $52.0 million was 33% of revenue, compared to $32.2 million and 30% of revenue in 2021

"In 2022, Schwazze continued to execute its strategy to "go deep" in our operating states and build customer loyalty and share," stated Justin Dye, CEO of Schwazze. "To date, we have opened, acquired, or announced pending acquisitions of 45 dispensaries with five operating cultivation and two manufacturing facilities across Colorado and New Mexico. We believe our retail brands are really connecting with customers. Schwazze is well-positioned to play offense in this challenging environment. As market forces become more favorable, we believe Schwazze will emerge with a much stronger position which will reward shareholders. For now, we will keep executing our strategy and playbook."

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo by Tim Foster on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsJustin Dyepremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.